In the Loop – August 15, 2025

“In The Loop” is designed to give you a short update reflecting major developments, earnings, and investment trends across some core Equity Income and Growth holdings. All clients should be aware that individual buy/sell recommendations will be conveyed directly to you on an individual basis. Have a great weekend.

“In the short run, the market is a voting machine, but in the long run, it is a weighing machine”. This quote is most often attributed to Benjamin Graham, considered the father of value investing and mentor to Warren Buffett. Graham originated this concept to explain how, in the short term, stock prices reflect the popularity and opinions of investors, while over the long term, true business fundamentals determine stock values. The massive performance divergence between Growth Stocks and Value Stocks in 2025 are supporting investors popularity for innovation and the future. At this time, I would caution investing in profit-less companies with high P/E multiples and stay with “Growth at a Reasonable Price” or Value stocks. Recently, we have seen Warren Buffet and David Tepper buying positions in beaten up United Healthcare.

Economy, Washington and The Federal Reserve

With new tariffs taking effect, growth is likely to slow and prices on affected goods to rise, leaving the Federal Reserve in the challenging position of managing inflation while the economy shows signs of cooling. While risks have increased, current data suggest a recession is not imminent, and we view market volatility — whether seasonal or driven by headlines — as a potential buying opportunity rather than a major cause for concern.

The sudden resignation of Federal Reserve Governor Adriana Kugler, four months before her term’s end in early 2026, has added fresh uncertainty to the monetary policy landscape. President Trump has nominated Stephen Miran, current Chair of the Council of Economic Advisors, to serve out her term, pending Senate confirmation, and speculation is building that Fed Governor Chris Waller — a Trump appointee and outspoken supporter of lower rates — could be tapped to replace Jerome Powell when his term as Fed Chair ends in May 2026. If Miran is confirmed before September, he will participate in the Fed’s remaining 2025 meetings and the January 2026 meeting, while Waller’s promotion could trigger another vacancy for the White House to fill. Altogether, the administration may appoint a new Fed Chair and two governors within the next year, potentially shifting the central bank toward a more dovish, rate-cut-friendly stance.

Corporate earnings point to continued U.S. economic resilience, though some consumer companies show weakness among lower-income households, with McDonald’s noting double-digit declines in visits from this group as they cut back on meals out. While tariffs will likely pressure these consumers further, their share of total spending is relatively small. With middle- and upper-income households benefiting from record equity values and net wealth, and absent major layoffs or a sharp market drop, overall spending should remain strong enough to sustain economic momentum.

Individual Company Updates

Vertiv Holdings (VRT)

Morgan Stanley lifted its price target for Vertiv to $165 from $125 and reiterated a Buy rating, citing strong Q2 2025 results, a 35% revenue surge to $2.64 billion, and raised full-year guidance. The AI infrastructure firm’s $8.5 billion order backlog and “phenomenal” first-half performance point to accelerating orders and favorable margin comparisons into fiscal 2026.

Broadcom (AVGO)

Broadcom deepened its strategic role in Apple’s supply chain with a multiyear, multibillion-dollar agreement to produce 5G and RF components at its Fort Collins, Colorado facility, supporting U.S. manufacturing. The company invested $9.5 billion in R&D in the 12 months through April 2025, boosting domestic innovation capacity.

Uber Technologies (UBER)

Uber’s Q2 2025 gross bookings rose 17% YoY to $46.8 billion, fueled by 20% delivery growth, while revenue climbed 18% to $12.8 billion. Adjusted EBITDA hit a record $2.12 billion and net income rose to $1.36 billion. The platform reached 180 million active users, with delivery reaccelerating and cross-platform initiatives—like $10B in delivery bookings from the Eats tab in the rideshare app—driving engagement. Uber One membership reached 36 million. Free cash flow hit a quarterly record of $2.48B and a TTM record of $8.5B, prompting a $20B share buyback program. Guidance for Q3 exceeded expectations, and analysts largely remain bullish despite some caution on AV competition.

MasTec (MTZ)

MasTec posted record Q2 2025 revenue of $3.5 billion (+20% YoY) and adjusted EPS of $1.49 (+50%), both ahead of guidance. The 18-month backlog jumped 23% to $16.5 billion, driven by Clean Energy, Communications, and Power Delivery. Federal incentives and grid modernization needs underpin a strong multi-year growth outlook.

Amgen (AMGN)

Amgen’s Q2 2025 revenue grew 9% to $9.2 billion, surpassing estimates, on a 13% rise in product volumes. Repatha sales jumped 31% and Evenity climbed 32%, leading broad-based double-digit growth across 15 products. Adjusted EPS rose 21% to $6.02, and GAAP EPS nearly doubled to $2.65. The company raised 2025 guidance and plans $2.3B in capital expenditures, with modest share repurchases.

EOG Resources (EOG)

EOG’s Q2 2025 production averaged 1.13 million boepd, up from 1.047 million a year earlier, helping offset a ~20% drop in Brent crude prices. Adjusted EPS of $2.32 topped estimates, and revenue of $5.5B beat forecasts despite an 8.8% YoY decline. Free cash flow approached $1B, supporting $528M in dividends and $600M in buybacks.

UnitedHealth Group (UNH)

UnitedHealth remains a core healthcare leader, with steady demand for insurance and healthcare services. Recent filings show insider purchases by CEO Andrew Witty and Director Stephen Hemsley, along with high-profile institutional buying from Warren Buffett’s Berkshire Hathaway and David Tepper’s Appaloosa Management in the past quarter—signaling strong conviction in the company’s long-term growth and resilience.

We remain focused on navigating market trends and positioning portfolios for long-term growth and resilience.
Share this article:

Formidable Asset Management (“Massey Romans Capital”) is an investment adviser registered under the Investment Advisers Act of 1940. The information presented in the material is general in nature and is not designed to address your investment objectives, financial situation or particular needs. Prior to making any investment decision, you should assess, or seek advice from a professional regarding whether any particular transaction is relevant or appropriate to your individual circumstances. Although taken from reliable sources, the Firm cannot guarantee the accuracy of the information received from third parties.

The opinions expressed herein are those of the Firm and may not actually come to pass.